Preimplantation Genetics Diagnosis Market is Growing With Promising Value of USD 92.0 Billion by 2030 | Invitae Corporation, Natera Inc, PacGenomics, PerkinElmer, Inc.

As per the report published by Allied Market Research, the global Preimplantation Genetics Diagnosis (PGD) Market was accounted for $81.52 billion in 2020, and is estimated to reach $217.19 billion by 2030, growing at a CAGR of 10.4% from 2021 to 2030.

Key Takeaways:

Growing Demand for Healthy Offspring: The primary driver of the PGD market is the increasing demand from couples who are carriers of genetic diseases or have a family history of genetic disorders. These couples seek to reduce the risk of passing on such conditions to their children.

Advancements in Genetic Testing Technologies: The PGD market benefits from ongoing advancements in genetic testing technologies. These include techniques such as polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), and next-generation sequencing (NGS), which enable the detection of a wide range of genetic abnormalities.

Expanding Range of Tested Conditions: Initially, PGD was used for single-gene disorders, such as cystic fibrosis and sickle cell anemia. However, the scope of PGD has expanded to include screening for chromosomal abnormalities like Down syndrome and sex-linked disorders, along with broader genetic panels.

Request Sample Copy of the Report:

https://www.alliedmarketresearch.com/request-sample/1470

By Genetic Condition:

Single-Gene Disorders: These are genetic disorders caused by mutations in a single gene, such as cystic fibrosis, sickle cell anemia, and Tay-Sachs disease.
Chromosomal Abnormalities: Conditions caused by changes in the number or structure of chromosomes, including Down syndrome, Turner syndrome, and Klinefelter syndrome.
Sex-Linked Disorders: Genetic conditions that are linked to the sex chromosomes, such as hemophilia and Duchenne muscular dystrophy.

By Technology:

Polymerase Chain Reaction (PCR): A technique used to amplify DNA for analysis, particularly suitable for detecting single-gene disorders.
Fluorescence In Situ Hybridization (FISH): A method to visualize and map the genetic material in an individual's cells, often used to identify chromosomal abnormalities.
Next-Generation Sequencing (NGS): High-throughput sequencing technologies used for analyzing multiple genes simultaneously, enabling broader genetic testing panels.

By Geography:

Asia-Pacific (China, Japan, India, South Korea, Rest Of Asia Pacific)
LAMEA (Latin America, Middle East, Africa)
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Rest of Europe)

By End User:

Fertility Clinics: Medical centers specializing in assisted reproductive technologies, where PGD is performed as part of IVF procedures.
Genetic Testing Laboratories: Facilities that specialize in genetic testing services, including PGD testing.

By Application:

Family Balancing: Couples seeking to choose the gender of their child for non-medical reasons.
Medical Reasons: Couples with a known genetic condition or history of genetic disorders who want to have a healthy child without the condition.

Request for Customization -

https://www.alliedmarketresearch.com/request-for-customization/1470

Competitive Landscape:

Agilent Technologies, Inc.
CeGaT GmbH
Illumina Inc., Illumina Inc.
Invitae Corporation
Laboratory Corporation of America Holdings
Natera Inc.
PacGenomics
PerkinElmer, Inc.
Quest Diagnostics Inc.
Reproductive Genetic Innovations (RGI)

Browse more latest healthcare reports:

RNA Based Therapeutics Market https://www.alliedmarketresearch.com/rna-based-therapeutics-market

Erythropoietin Drugs Market https://www.alliedmarketresearch.com/erythropoietin-market

Biosimilars Market https://www.alliedmarketresearch.com/global-biosimilars-market

Medical Implant Market https://www.alliedmarketresearch.com/medical-implants-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.